A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer

PURPOSE: To compare biochemical recurrence-free survival (BRFS) and toxicity outcomes of high dose rate brachytherapy (HDRB) and stereotactic body radiotherapy (SBRT) boost after elective nodal irradiation for high/very high-risk prostate cancer. MATERIALS AND METHODS: A retrospective analysis was p...

Descripción completa

Detalles Bibliográficos
Autores principales: Novikov, Sergey Nikolaevich, Novikov, Roman Vladimirovich, Merezhko, Yurii Olegovich, Gotovchikova, Mariya Yurevna, Ilin, Nikolai Dmitrievich, Melnik, Yulia Sergeevna, Kanaev, Sergey Vasilevich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535414/
https://www.ncbi.nlm.nih.gov/pubmed/36200309
http://dx.doi.org/10.3857/roj.2022.00339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535414/
https://www.ncbi.nlm.nih.gov/pubmed/36200309
http://dx.doi.org/10.3857/roj.2022.00339

Ejemplares similares